To evaluate the efficacy of cutis capsule and cutis oil in Atopic Eczema

A randomized open labelled , parallel group study to evaluate the safety and efficacy of cutis capsule and cutis oil in Atopic Eczema

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/11/010570

Enrollment

Registered

2017-11-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Suffering from atopic eczema with EASI score 15

Interventions

Intervention1: Cutis capsule: Cutis capsule- ingredients- Mahamanjisthadi kwath,Panchnimba churn,Triphala churn,Acacia catechu,Tinospora cordifolia,Curcuma longa,Ganthak rasayan Mode of administration

Eligibility

Inclusion criteria

Inclusion criteria: 1. Non pregnant,non lactating females 2. Patient with atopic eczema according to Rajka and Hanifin criteria 3. Patient with EASI score 15 at time of screening

Exclusion criteria

Exclusion criteria: 1. Pregnant,lactating mother 2. Patient with infected atopic eczema 3. Patient with severe systemic disorder 4. Patient with known hypersensitivity to excipients of drugs

Design outcomes

Primary

Measure	Time frame
Change in the eczematic area and skin moisture level at end of study Â Timepoint: 0 day and 56th Day of the study	—

Secondary

Measure	Time frame
EASI score, SCORAD score,DLQI score at starting and at end of studyTimepoint: at 14 days,28 days,after 56 days	—

Countries

India

Contacts

Public ContactDrRajesh Sood

Rajiv Gandhi Govt. Post Graduate Ayurvedic College and Hospital, PaprolaÂ

drrajeshsood@gmail.com9418102424

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026